Stock Taper 
BAKER BROS. ADVISORS LP
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 ACADIA Pharmaceuticals Inc. | ACAD | 42.91M | $1.09B |
 Summit Therapeutics Inc. | SMMT | 32.79M | $477.7M |
 Incyte Corporation | INCY | 30.76M | $3.49B |
 Kodiak Sciences Inc. | KOD | 19.92M | $776.05M |
 Revolution Medicines, Inc. | RVMD | 11.44M | $2.14B |
 Replimune Group, Inc. | REPL | 11.05M | $122.27M |
 Alkermes plc | ALKS | 10.01M | $524.59M |
 BeOne Medicines AG | ONC | 8.8M | $2.51B |
 Insmed Incorporated | INSM | 8.8M | $937.84M |
 Kymera Therapeutics, Inc. | KYMR | 8.66M | $992.73M |
 Celcuity Inc. | CELC | 7.92M | $828.15M |
 Cerus Corporation | CERS | 6.4M | $18.67M |
 Rhythm Pharmaceuticals, Inc. | RYTM | 5.6M | $622.27M |
 Immunovant, Inc. | IMVT | 5.44M | $209.42M |
 Entrada Therapeutics, Inc. | TRDA | 5.07M | $37.34M |
 IDEAYA Biosciences, Inc. | IDYA | 5.01M | $186.72M |
 Roivant Sciences Ltd. | ROIV | 4.72M | $166.93M |
 Nurix Therapeutics, Inc. | NRIX | 4.66M | $113.02M |
 Monte Rosa Therapeutics, Inc. | GLUE | 4.35M | $105.17M |
 GRAIL Inc. | GRAL | 4.03M | $275.03M |